adherence – Medxy AI

Unraveling Adherence Challenges to Bone Conduction Hearing Devices in Pediatric Microtia Patients

By MedXY 09/13/2026

This study identifies unilateral hearing loss, older age, and insurance status as key factors associated with poor adherence to bone conduction hearing devices in children with microtia, emphasizing the critical role of routine monitoring of device usage via datalogging.

Clinical Updates Neurology news OB/GYN & Women's Health

Feasibility and Patient-Centered Insights from a Pilot Trial of Home-Based Cognitive Training for Cognitive Impairment in Gynecologic Cancer Survivors

By MedXY 08/24/2026

This review synthesizes evidence on home-based cognitive training feasibility, adherence, and patient experiences in gynecologic cancer survivors with CRCI, highlighting clinical implications and directions for optimized intervention design.

news OB/GYN & Women’s Health Public Health

Low-Dose Aspirin’s Pregnancy Benefit Appears Unchanged by Start Time or Adherence in a Large Multicentre Post Hoc Trial Analysis

By MedXY 05/11/2026

In this post hoc analysis of a large randomized pregnancy trial, aspirin’s effects on preterm birth and perinatal mortality were not meaningfully modified by gestational age at initiation or measured adherence.

news Otorhinolaryngology

Pre-Fitting Predictors of 2‑Year Hearing Aid Use in 284,175 US Veterans: When Patient Context Matters More Than Audiometry

By MedXY 11/04/2025

In 284,175 US veterans, nonmodifiable pre‑fitting factors—health comorbidity, mental status, prior hearing‑aid experience, age, race/ethnicity, and partnership—were independently associated with 2‑year hearing‑aid use persistence, beyond audiometric severity.

AI Cardiology news Rehabilitation Medicine

Harnessing Wearable Technology to Boost Cardiac Rehabilitation Adherence in CHD Patients: Insights from a Randomized Trial

By MedXY 10/24/2025

This study evaluates how smartwatch-assisted home-based cardiac rehab improves exercise adherence and health outcomes in coronary heart disease patients.

Gastroenterology Internal Medicine

Simplifying Ulcerative Colitis Treatment: Evaluating a Single 1600 mg 5-ASA Tablet Regimen in the EASI Trial

By MedXY 10/09/2025

The EASI trial compared a once-daily 1600 mg 5-ASA tablet with the conventional three 800 mg tablet regimen for ulcerative colitis, finding similar adherence and relapse rates, suggesting a feasible simpler alternative.